CHANGE IN RATINGS
Abercrombie & Fitch (FBR Quote) upgraded at FBR to Outperform from Market Perform based on a change in promotional philosophy and a positive effect on recent clearance sales. Price target increased to $37 from $21.CB Richard Ellis (CBRE Quote) upgraded at Goldman Sachs to Neutral from Sell based on valuation. Expect transaction activity to remain low and note constrained capital resources. See potential for earnings recovery but prefer JLL based on more appropriate leverage ratios as well as segment and geographic diversity. Price target at $7.
Coventry Health Care (CVH Quote) downgraded at UBS to Neutral from Buy. Links to macroeconomic factors and stretched valuation has led to the decrease in ratings. Maintains target price of $19.
Dolby Laboratories (DLB Quote) upgraded at JPMorgan to Overweight from Neutral based on valuation. Recent pullback provides opportunity to buy shares of long-term growth stock at reasonable levels. Note that consumer electronics demand appears to be stabilizing, and company is poised to benefit from strength in Blu-ray players and DTV/Broadcasting. Price target raised to $44.50 from $41.50. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,456.54 | 1,105.57 | 2,189.50 | 35.48 |
Oil *
72.04
|
|
UP
50.71
|
UP
3.22
|
DOWN
1.36
|
UP
0.66
|
10 Yr
3.55%
SPDR Gold
109.66
|
|
+0.49%
|
+0.29%
|
-0.06%
|
+1.90%
|
Data delayed 20 minutes |
Connect with TheStreet